Literature DB >> 5023324

Perfusion of the isolated rat liver with erythromycin estolate and other derivatives.

J Kendler, S Anuras, O Laborda, H J Zimmerman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5023324     DOI： 10.3181/00379727-139-36345

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  4 in total

1.  WHO's international drug monitoring--the formative years, 1968-1975: preparatory, pilot and early operational phases.

Authors:  Jan Venulet; Margaretha Helling-Borda
Journal:  Drug Saf       Date:  2010-07-01       Impact factor: 5.606

2.  Cholestatic and hepatocellular injury associated with erythromycin esters: report of nine cases.

Authors:  E S Zafrani; K G Ishak; C Rudzki
Journal:  Dig Dis Sci       Date:  1979-05       Impact factor: 3.199

3.  Therapeutic doses of erythromycin esteolate is not cholestatic in rats in vivo.

Authors:  I Fiebiger; M S Anwer; D Hegner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-05       Impact factor: 3.000

4.  Various forms of chemically induced liver injury and their detection by diagnostic procedures.

Authors:  H J Zimmerman
Journal:  Environ Health Perspect       Date:  1976-06       Impact factor: 9.031
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.